Product Images Losortan Potassium

This appears to be a graph or chart showing the percentage of patients with a particular primary endpoint for two different medications, Atenolol and Losartan Potassium, over a period of 66 months. The adjusted risk reduction and p-value are also provided. Without more context or additional information, it is difficult to provide a more specific description of the data.*

This is a medical-related text mentioning two drugs, Atenolol and Losartan Potassium. The text also displays a statistic of adjusted risk reduction of 25% with a p-value of 0.001, related to some sort of study. The rest of the text seems to represent a graph, displaying study months or time periods.*

This is a medical report that contains information related to stroke and the patient's medical condition. Unfortunately, due to errors, the text is not completely readable.*

This is a clinical trial result demonstrating the efficacy of Losartan Potassium Tablet in reducing risks of an event in comparison to a placebo. The percentage of patients with an event is 40 and the risk reduction offered by Losartan Potassium Tablet is 16.1%. The P-value is 0.022. The numbers at the bottom could represent a time period.*